<p>Hidradenitis suppurativa (HS) is a&#xa0;chronic inflammatory skin disease that causes painful abscesses and fistulas primarily in intertriginous areas. The new 2024 S2k guideline provides a&#xa0;comprehensive understanding of its pathogenesis and corresponding new treatment options. This highly psychologically and socioeconomically burdensome disease, which primarily affects young adults, presents a&#xa0;significant therapeutic challenge. Treatment depends on the stage and activity of the disease. Topical, physical, and multimodal systemic therapies in combination with surgical procedures should be used. The long-term goal is adequate control of inflammation to prevent disease progression.</p>

错误:搜索内容不能为空,请输入英文关键词
错误:关键词超出字数限制,请精简
高级检索

Neue S2k-Leitlinie zur Hidradenitis suppurativa

  • Markus K. Erbel,
  • Leif C. Wagner

摘要

Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease that causes painful abscesses and fistulas primarily in intertriginous areas. The new 2024 S2k guideline provides a comprehensive understanding of its pathogenesis and corresponding new treatment options. This highly psychologically and socioeconomically burdensome disease, which primarily affects young adults, presents a significant therapeutic challenge. Treatment depends on the stage and activity of the disease. Topical, physical, and multimodal systemic therapies in combination with surgical procedures should be used. The long-term goal is adequate control of inflammation to prevent disease progression.